M. Malvezzi, G. Carioli, P. Bertuccio, T. Rosso, P. Boffetta et al., European cancer mortality predictions for the year 2016 with focus on leukaemias, Ann Oncol, vol.27, issue.4, pp.725-756, 2016.

M. Ilic and I. Ilic, Epidemiology of pancreatic cancer, World J Gastroenterol, vol.22, issue.44, pp.9694-705, 2016.

R. L. Siegel, K. D. Miller, and A. Jemal, Cancer Statistics, 2017. CA Cancer J Clin, vol.67, pp.7-30, 2017.

J. A. Pietryga and D. E. Morgan, Imaging preoperatively for pancreatic adenocarcinoma, J Gastrointest Oncol, vol.6, issue.4, pp.343-57, 2015.

T. Kamisawa, L. D. Wood, T. Itoi, and K. Takaori, Pancreatic cancer. The Lancet, vol.388, pp.73-85, 2016.

C. Bosetti, P. Bertuccio, E. Negri, L. Vecchia, C. Zeegers et al., Pancreatic cancer: overview of descriptive epidemiology, Mol Carcinog, vol.51, issue.1, pp.3-13, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01262967

M. Hidalgo, S. Cascinu, J. Kleeff, R. Labianca, J. Löhr et al., Addressing the challenges of pancreatic cancer: future directions for improving outcomes, Pancreatology, vol.15, issue.1, pp.8-18, 2015.

J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers et al., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, vol.136, issue.5, pp.359-386, 2015.

T. P. Yeo, Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma, Semin Oncol, vol.42, issue.1, pp.8-18, 2015.

D. M. Parkin, L. Boyd, and L. C. Walker, The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010, Br J Cancer, vol.16, issue.2, pp.77-81, 2011.

M. Ezzati, S. J. Henley, A. D. Lopez, and M. J. Thun, Role of smoking in global and regional cancer epidemiology: current patterns and data needs, Int J Cancer, vol.116, issue.6, pp.963-71, 2005.

P. Anand, A. B. Kunnumakkara, A. B. Kunnumakara, C. Sundaram, K. B. Harikumar et al., Cancer is a preventable disease that requires major lifestyle changes, Pharm Res, vol.25, issue.9, pp.2097-116, 2008.

A. Ekbom, J. K. Mclaughlin, B. M. Karlsson, O. Nyrén, G. Gridley et al., Pancreatitis and pancreatic cancer: a population-based study, J Natl Cancer Inst, vol.86, issue.8, pp.625-632, 1994.

P. Maisonneuve and A. B. Lowenfels, Risk factors for pancreatic cancer: a summary review of meta-analytical studies, Int J Epidemiol, vol.44, issue.1, pp.186-98, 2015.

K. E. Poruk, D. Z. Gay, K. Brown, J. D. Mulvihill, K. M. Boucher et al., The Clinical Utility of CA 19-9 in Pancreatic Adenocarcinoma: Diagnostic and Prognostic Updates, Curr Mol Med, vol.13, issue.3, pp.340-51, 2013.

M. T. Huggett and S. P. Pereira, Diagnosing and managing pancreatic cancer, Practitioner, vol.255, pp.21-24, 1742.

R. J. Geer and M. F. Brennan, Prognostic indicators for survival after resection of pancreatic adenocarcinoma, Am J Surg, vol.165, issue.1, pp.72-73, 1993.

M. A. Tempero, E. Uchida, H. Takasaki, D. A. Burnett, Z. Steplewski et al., Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer, Cancer Res, vol.47, issue.20, pp.5501-5504, 1987.

J. C. Wong and D. Lu, Staging of pancreatic adenocarcinoma by imaging studies, Clin Gastroenterol Hepatol, vol.6, issue.12, pp.1301-1309, 2008.

R. W. Prokesch, L. C. Chow, C. F. Beaulieu, R. Bammer, and R. B. Jeffrey, Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs, Radiology, vol.224, issue.3, pp.764-772, 2002.

S. H. Yoon, J. M. Lee, J. Y. Cho, K. B. Lee, J. E. Kim et al., Small (? 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT, Radiology, vol.259, issue.2, pp.442-52, 2011.

F. Chen, J. Ni, Z. Zhang, L. Zhang, B. Li et al., Presurgical Evaluation of Pancreatic Cancer: A Comprehensive Imaging Comparison of CT Versus MRI, American Journal of Roentgenology, vol.206, issue.3, pp.526-561, 2016.

H. S. Park, J. M. Lee, H. K. Choi, S. H. Hong, J. K. Han et al., Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT, J Magn Reson Imaging, vol.30, issue.3, pp.586-95, 2009.

J. H. Kim, S. H. Park, E. S. Yu, M. Kim, J. Kim et al., Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations, Radiology, vol.257, issue.1, pp.87-96, 2010.

Y. Wang, F. H. Miller, Z. E. Chen, L. Merrick, K. J. Mortele et al., Diffusionweighted MR imaging of solid and cystic lesions of the pancreas, Radiographics, vol.31, issue.3, pp.47-64, 2011.

K. Holzapfel, C. Reiser-erkan, A. A. Fingerle, M. Erkan, M. J. Eiber et al., Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer, Abdom Imaging, vol.36, issue.2, pp.179-84, 2011.

C. Chew, O. Dwyer, and P. J. , The value of liver magnetic resonance imaging in patients with findings of resectable pancreatic cancer on computed tomography, Singapore Med J, vol.57, issue.6, pp.334-342, 2016.

M. A. Eloubeidi and A. Tamhane, Prospective assessment of diagnostic utility and complications of endoscopic ultrasound-guided fine needle aspiration. Results from a newly developed academic endoscopic ultrasound program, Dig Dis, vol.26, issue.4, pp.356-63, 2008.

A. S?ftoiu and P. Vilmann, Role of endoscopic ultrasound in the diagnosis and staging of pancreatic cancer, J Clin Ultrasound, vol.37, issue.1, pp.1-17, 2009.

H. Nawaz, C. Yi-fan, J. Kloke, A. Khalid, K. Mcgrath et al., Performance Characteristics of Endoscopic Ultrasound in the Staging of Pancreatic Cancer: A Meta-Analysis, JOP, vol.14, issue.5, pp.484-97, 2013.

Z. Wang, J. Chen, J. Liu, X. Qin, and Y. Huang, FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: A meta-analysis, World J Gastroenterol, vol.19, issue.29, pp.4808-4825, 2013.

A. P. Rijkers, R. Valkema, H. J. Duivenvoorden, and C. Van-eijck, Usefulness of F-18fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis, Eur J Surg Oncol, vol.40, issue.7, pp.794-804, 2014.

R. Kim, G. Prithviraj, N. Kothari, G. Springett, M. Malafa et al., PET/CT Fusion Scan prevents futile laparotomy in early pancreatic cancer, Clin Nucl Med, vol.40, issue.11, pp.501-506, 2015.

C. Micames, P. S. Jowell, R. White, E. Paulson, R. Nelson et al., Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA, Gastrointest Endosc, vol.58, issue.5, pp.690-695, 2003.

M. Ducreux, A. S. Cuhna, C. Caramella, A. Hollebecque, P. Burtin et al., Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, issue.5, pp.56-68, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01810223

A. Francis, I. R. Chari, S. T. Fishman, E. K. Hough, D. M. Lu et al., Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association, Radiology, vol.270, issue.1, pp.248-60, 2014.

M. P. Callery, K. J. Chang, E. K. Fishman, M. S. Talamonti, W. Traverso et al., Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement, Ann Surg Oncol, vol.16, issue.7, pp.1727-1760, 2009.

J. M. Winter, J. L. Cameron, K. A. Campbell, M. A. Arnold, D. C. Chang et al., 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience, J Gastrointest Surg, vol.10, issue.9, pp.1210-1211, 2006.

K. Y. Bilimoria, M. S. Talamonti, S. F. Sener, M. M. Bilimoria, A. K. Stewart et al., Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer, J Am Coll Surg, vol.207, issue.4, pp.510-519, 2008.

C. M. Schmidt, E. S. Powell, C. T. Yiannoutsos, T. J. Howard, E. A. Wiebke et al., A 20-Year Experience in 516 Patients, Arch Surg, vol.139, issue.7, pp.718-745, 2004.

C. Palanivelu, P. S. Rajan, M. Rangarajan, V. Vaithiswaran, P. Senthilnathan et al., Evolution in techniques of laparoscopic pancreaticoduodenectomy: a decade long experience from a tertiary center, J Hepatobiliary Pancreat Surg, vol.16, issue.6, pp.731-771, 2009.

K. Shimada, Y. Sakamoto, S. Nara, M. Esaki, T. Kosuge et al., Analysis of 5Year Survivors After a Macroscopic Curative Pancreatectomy for Invasive Ductal Adenocarcinoma, World J Surg, vol.34, issue.8, pp.1908-1923, 2010.

V. J. Picozzi, S. Y. Oh, A. Edwards, M. T. Mandelson, R. Dorer et al., FiveYear Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective, Ann Surg Oncol, pp.1-9, 2017.

R. Fischer, M. Breidert, T. Keck, F. Makowiec, C. Lohrmann et al., Early Recurrence of Pancreatic Cancer after Resection and During Adjuvant Chemotherapy, Saudi J Gastroenterol, vol.18, issue.2, pp.118-139, 2012.

K. J. Labori, M. H. Katz, C. W. Tzeng, B. A. Bjørnbeth, M. Cvancarova et al., Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma-A populationbased cohort study, Acta Oncol, vol.55, issue.3, pp.265-77, 2016.

Y. Yamamoto, H. Ikoma, R. Morimura, H. Konishi, Y. Murayama et al., Optimal duration of the early and late recurrence of pancreatic cancer after pancreatectomy based on the difference in the prognosis, Pancreatology, vol.14, issue.6, pp.524-533, 2014.

K. Shimada, Y. Sakamoto, T. Sano, and T. Kosuge, The Role of Paraaortic Lymph Node Involvement on Early Recurrence and Survival after Macroscopic Curative Resection with Extended Lymphadenectomy for Pancreatic Carcinoma, Journal of the American College of Surgeons, vol.203, issue.3, pp.345-52, 2006.

T. Fouquet, A. Germain, L. Brunaud, L. Bresler, and A. Ayav, Is Perineural Invasion More Accurate Than Other Factors to Predict Early Recurrence after Pancreatoduodenectomy for Pancreatic Head Adenocarcinoma?, World J Surg, vol.38, issue.8, pp.2132-2139, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01688819

M. Waraya, K. Yamashita, H. Katagiri, K. Ishii, Y. Takahashi et al., Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer, Ann Surg Oncol, vol.16, issue.5, pp.1231-1271, 2009.

K. Shimada, Y. Sakamoto, T. Sano, and T. Kosuge, The Role of Paraaortic Lymph Node Involvement on Early Recurrence and Survival after Macroscopic Curative Resection with Extended Lymphadenectomy for Pancreatic Carcinoma, Journal of the American College of Surgeons, vol.203, issue.3, pp.345-52, 2006.

K. Nishio, K. Kimura, R. Amano, S. Yamazoe, G. Ohrira et al., Preoperative predictors for early recurrence of resectable pancreatic cancer, World Journal of Surgical Oncology, vol.15, issue.1, p.16, 2017.

M. Katz, P. Pisters, J. E. Lee, and J. B. Fleming, Borderline resectable pancreatic cancer: what have we learned and where do we go from here?, Ann Surg Oncol, vol.18, issue.3, pp.608-618, 2011.

J. Tol, D. J. Gouma, C. Bassi, C. Dervenis, M. Montorsi et al., Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS), Surgery, vol.156, issue.3, pp.591-600, 2014.

C. Gómez-mateo-m-del, L. Sabater-ortí, and A. Ferrández-izquierdo, Pathology handling of pancreatoduodenectomy specimens: Approaches and controversies, World J Gastrointest Oncol, vol.6, issue.9, pp.351-360, 2014.

J. R. Delpero, J. M. Boher, A. Sauvanet, L. Treut, Y. P. Sa-cunha et al., Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie, Ann Surg Oncol, vol.22, issue.6, pp.1874-83, 2015.

N. D. Arvold, A. Niemierko, H. J. Mamon, C. Fernandez-del-castillo, and T. S. Hong, Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning, Int J Radiat Oncol Biol Phys, vol.80, issue.5, pp.1383-90, 2011.

K. Y. Paik, S. H. Choi, J. S. Heo, and D. W. Choi, Analysis of liver metastasis after resection for pancreatic ductal adenocarcinoma, World Journal of Gastrointestinal Oncology, vol.4, issue.5, p.109, 2012.

J. L. Williams, C. K. Chan, P. A. Toste, I. A. Elliott, C. R. Vasquez et al., Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival, JAMA Surg, vol.152, issue.1, pp.82-90, 2017.

S. P. Raman, S. Reddy, M. J. Weiss, L. L. Manos, J. L. Cameron et al., Impact of the Time Interval Between MDCT Imaging and Surgery on the Accuracy of Identifying Metastatic Disease in Patients With Pancreatic Cancer, AJR Am J Roentgenol, vol.204, issue.1, pp.37-42, 2015.

A. A. Khorana, P. B. Mangu, J. Berlin, A. Engebretson, T. S. Hong et al., Potentially Curable Pancreatic Cancer, Clinical Oncology Clinical Practice Guideline. JCO, vol.34, issue.21, pp.2541-56, 2016.

K. Takaori, C. Bassi, A. Biankin, T. B. Brunner, I. Cataldo et al., International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer, Pancreatology, vol.16, issue.1, pp.14-27, 2016.

K. Lai, K. Cheng, L. Jeng, C. Huang, Y. Lee et al., Factors associated with treatment failure of percutaneous catheter drainage for pyogenic liver abscess in patients with hepatobiliary-pancreatic cancer, The American Journal of Surgery, vol.205, issue.1, pp.52-59, 2013.

V. Vilgrain, M. Ronot, M. Abdel-rehim, M. Zappa, G. Assignies et al., Hepatic steatosis: A major trap in liver imaging. Diagnostic and Interventional Imaging, juillet, vol.94, issue.7-8, pp.713-740, 2013.

J. Chen, M. Bhandari, D. S. Astill, T. G. Wilson, L. Kow et al., Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion. HPB (Oxford), vol.12, pp.101-109, 2010.

A. Bilici, Prognostic factors related with survival in patients with pancreatic adenocarcinoma, World J Gastroenterol, vol.20, issue.31, pp.10802-10814, 2014.

B. J. Kwak, S. C. Kim, K. Song, J. H. Lee, D. W. Hwang et al., Prognostic factors associated with early mortality after surgical resection for pancreatic adenocarcinoma, Korean J Hepatobiliary Pancreat Surg, vol.18, issue.4, pp.138-184, 2014.

Y. W. Tien, H. Kuo, B. Ho, M. Chang, Y. Chang et al., A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer, Medicine, issue.16, p.95, 2016.

T. Kuroki and S. Eguchi, No-touch isolation techniques for pancreatic cancer. Surg Today, vol.47, pp.8-13, 2017.

T. Gall, J. Jacob, A. E. Frampton, J. Krell, C. Kyriakides et al., Reduced Dissemination of Circulating Tumor Cells With No-Touch Isolation Surgical Technique in Patients With Pancreatic Cancer, JAMA Surg, vol.149, issue.5, pp.482-487, 2014.

F. Mierke, S. Hempel, M. Distler, D. E. Aust, H. Saeger et al., Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection, Ann Surg Oncol, vol.23, issue.5, pp.730-736, 2016.

L. Rahib, B. D. Smith, R. Aizenberg, A. B. Rosenzweig, J. M. Fleshman et al., Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States, Cancer Res, vol.74, issue.11, pp.2913-2934, 2014.

Y. Okamura, H. Sugimoto, S. Yamada, T. Fujii, S. Nomoto et al., Risk factors for hepatic steatosis after pancreatectomy: a retrospective observational cohort study of the importance of nutritional management, Pancreas, vol.41, issue.7, pp.1067-72, 2012.

T. J. Kröncke, M. Taupitz, D. Kivelitz, I. Scheer, U. Daberkow et al., Multifocal nodular fatty infiltration of the liver mimicking metastatic disease on CT: imaging findings and diagnosis using MR imaging, Eur Radiol, vol.10, issue.7, pp.1095-100, 2000.

H. M. Patton and J. E. Lavine, Focal Fatty Liver. Gastroenterol Hepatol (N Y), vol.3, pp.199-200, 2007.

D. Burgio, M. Bruno, O. Agnello, F. Torrisi, C. Vernuccio et al., The cheating liver: imaging of focal steatosis and fatty sparing, Expert Rev Gastroenterol Hepatol, vol.10, issue.6, pp.671-679, 2016.

M. V. Perini, A. L. Montagnini, R. Coudry, R. Patzina, S. Penteado et al., Prognostic significance of epidermal growth factor receptor overexpression in pancreas cancer and nodal metastasis, ANZ J Surg, vol.85, issue.3, pp.174-182, 2015.

D. Catenacci, C. G. Chapman, P. Xu, A. Koons, V. J. Konda et al., Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound, Gastroenterology, vol.149, issue.7, pp.1794-1803, 2015.